melatonin and n-vinyl-2-pyrrolidinone

melatonin has been researched along with n-vinyl-2-pyrrolidinone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ji, CW; Kim, TW; Lee, BJ; Shim, SY1
Beilman, GJ; Suryanarayanan, R; Thakral, S; Wolf, A1
Beilman, GJ; Mulier, KE; Suryanarayanan, R; Thakral, S; Wolf, A1
Ioannou, E; Kapoti, S; Kikionis, S; Roussis, V; Siamidi, A; Tragou, K; Tsotinis, A; Vlachou, M1
Ioannou, E; Kikionis, S; Roussis, V; Siamidi, A; Tragou, K; Tsotinis, A; Vlachou, M1

Other Studies

5 other study(ies) available for melatonin and n-vinyl-2-pyrrolidinone

ArticleYear
Modified release of coated sugar spheres using drug-containing polymeric dispersions.
    Archives of pharmacal research, 2007, Volume: 30, Issue:1

    Topics: Acrylic Resins; Carbohydrates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Ethanol; Excipients; Hydrogen-Ion Concentration; Melatonin; Plasticizers; Povidone; Solubility; Solvents; Technology, Pharmaceutical; Time Factors

2007
Development and in vivo evaluation of a novel lyophilized formulation for the treatment of hemorrhagic shock.
    International journal of pharmaceutics, 2018, Feb-15, Volume: 537, Issue:1-2

    Topics: 3-Hydroxybutyric Acid; Animals; Chemistry, Pharmaceutical; Dimethyl Sulfoxide; Disease Models, Animal; Freeze Drying; Male; Melatonin; Povidone; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Solubility

2018
Evaluation of novel formulations of d-β-hydroxybutyrate and melatonin in a rat model of hemorrhagic shock.
    International journal of pharmaceutics, 2018, Sep-05, Volume: 548, Issue:1

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; 3-Hydroxybutyric Acid; Animals; Dimethyl Sulfoxide; Disease Models, Animal; Male; Melatonin; Povidone; Rats, Sprague-Dawley; Shock, Hemorrhagic

2018
Fabrication and Characterization of Electrospun Nanofibers for the Modified Release of the Chronobiotic Hormone Melatonin.
    Current drug delivery, 2019, Volume: 16, Issue:1

    Topics: Administration, Oral; Cellulose; Central Nervous System Depressants; Delayed-Action Preparations; Drug Liberation; Gelatin; Hypromellose Derivatives; Melatonin; Nanocapsules; Nanocomposites; Povidone; Sleep Wake Disorders

2019
Modified In Vitro Release of Melatonin Loaded in Nanofibrous Electrospun Mats Incorporated Into Monolayered and Three-Layered Tablets.
    Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:2

    Topics: Cellulose; Central Nervous System Depressants; Delayed-Action Preparations; Drug Liberation; Melatonin; Nanofibers; Povidone; Solubility; Tablets

2019